Miles White - Abbott
Total Compensation: $25.6 million
Details: After a rough year of declining company stock prices and FDA pressure that delayed new drug approvals, Abbott CEO and Chairman Miles White saw his total 2010 pay drop 2.5 percent to $25.6 million from 2009's $26.2 million. Although he received a two percent raise in base salary--to $1.89 million--White's stock awards took a significant 12 percent hit, accounting for the majority of his lost compensation.
The company is showing promise with its first quarter earnings in 2011, with an 18 percent rise in sales, in part thanks to its arthritis drug Humira. Its global revenue increased by 17.4 percent to $9.04 billion.
Abbott Labs News:
Abbott: Kaletra HIV med 'clobbered' by rivals
Abbott merges U.S., foreign pharma units under new chief
Abbott to axe another 1,900 jobs
Jury: Abbott breached GSK deal, but not competition law